cular dementia, 25 frontotemporal dementia and 21 Lewy body dementia or Parkinson's disease dementia. Sleep disorders were investigated with a battery of standardized questions and questionnaires. Results: Over 60% of persons had one or more sleep disturbances almost invariably associated one to another without any evident and specific pattern of co-occurrence. Persons with Alzheimer's disease and those with mild cognitive impairment had the same frequency of any sleep disorder. Sleep-disordered breathing was more frequent in vascular dementia. REM behavior disorder was more represented in Lewy body or Parkinson's disease dementia. Conclusion: A careful clinical evaluation of sleep disorders should be performed routinely in the clinical setting of persons with cognitive decline. Instrumental supports should be used only in selected patients. 
Introduction
The prevalence of sleep disturbances increases with age suggesting that sleep is affected by aging itself and/or by aging-related conditions [1, 2] . Excessive daytime sleepiness (EDS) is highly frequent in neurodegenerative disorders [3, 4] that are the most common chronic brain diseases of elderly people. In particular, sleep disturbances have been reported in 25-44% of patients with Alzheimer's disease (AD) [5] .
The high prevalence of sleep disorders reported in neurodegenerative diseases could be explained by intrinsic changes specific to each form of dementia but also by the high prevalence of non-specific conditions potentially affecting sleep in these patients (depression, chronic pain and bedrest, medication use) [6] . In addition, sleep can be affected by circadian rhythm changes and primary sleep disorders (PSD): in elderly persons, PSD are mainly represented by sleep-disordered breathing (SDB), REM parasomnias, in particular REM behavior disorder (RBD), restless legs syndrome (RLS) and periodic limb movements (PLM) [7] . It is highly plausible that the diffuse brain damage that characterizes dementias might extend over the cognitive brain areas, to involve the neural networks that control sleep function (anterior hypothalamus, reticular activating system, suprachiasmatic nucleus and pineal gland). Sleep disorders seem to be different in each form of dementia and this might be the consequence of the different brain pathological involvement that characterizes each dementia type [8] [9] [10] [11] [12] .
Our understanding of the basic mechanisms of sleep/ wake disturbances and their epidemiology in cognitive decline is quite important in the evaluation of persons with dementia since their presence might contribute to elucidate the type of structural neurological alterations. As an example, SDB is expected to be more frequent in diseases involving respiratory and autonomic neurons as Lewy body dementia (LBD) Parkinson's disease dementia (PDD) and multiple system atrophy (MSA), but they are also present in AD. RBD is frequently reported in Parkinson's disease (PD), LBD, MSA [13] and several studies showed that this disorder may even precede the clinical onset of synucleinopathies [14] .
Sleep disorders are not exclusively seen in neurodegenerative dementias since a high prevalence of obstructive sleep apnea (OSA) is observed also in patients with vascular cognitive impairment [15, 16] .
Mild cognitive impairment (MCI) is considered a risk condition for dementia, especially AD [17] ; RBD and other sleep disorders are associated with cognitive impairment and, in persons with MCI, the presence of particular sleep disturbances might identify persons at higher risk of evolving to AD or other forms of dementia [18] .
Although there is wide agreement that sleep disorders represent a relevant problem in neurodegenerative and vascular dementias, no previous studies investigated these disorders simultaneously in a wide population of persons with the main forms of dementia and in MCI, using standardized instruments. The aim of this multicenter study was to describe frequency and characteristics of sleep disorders in a large cohort of communitydwelling persons with dementia or MCI.
Subjects and Methods

Participants
Consecutive community-dwelling patients with dementia or MCI were enrolled by 10 Italian neurological centers over a period of 6 months. The diagnosis of dementia was made according to the DSM-IV-TR criteria [19] . AD and VaD were diagnosed respectively according to NINCS-ARDRA and NINDS-AIREN criteria [20, 21] . LBD and PDD, frontotemporal dementia (FTD) and MCI were diagnosed according to specific consensus guidelines [22, 23] .
Each participating center declared in advance the total number of patients that was possible to enroll. This predefined total number was divided in each center as follows: 50% AD, 25% MCI, 15% FTD, LBD/PDD, 10% VaD. Patients with life expectancy of less than 6 months, with a score of dementia severity at the Clinical Dementia Rating Scale [24] of more than 3 and patients not supported by a reliable caregiver were excluded. All the patients were evaluated in each participating center by a single neurologist expert in dementia and sleep disturbances.
Because the aim of the study is to describe type, frequency and characteristics of sleep disorders in patients with different type of dementia and MCI, no control (i.e. not cognitively impaired) group of patients was enrolled.
Demographic and Clinical Data
For each included patient we registered age, sex, education and some basic clinical information regarding the characteristics of dementia. In particular, for what concerns the variables considered in this study, we estimated the severity of dementia with the Mini-Mental State Examination (MMSE) [25] , and the severity of depressive symptoms with the Beck Depression Inventory-II (BD-III) [26] . Functional impairment was evaluated with the Physical Self-Maintenance Scale (PSMS) [27] and in a selected group of patients, the Italian version of the Disability Assessment for Dementia scale has been used [28] .
Sleep Disorders Evaluation
Sleep was investigated directly to the patient and/or the direct and reliable caregiver with a battery of questionnaires whenever possible standardized and validated with definite and acceptable values of sensitivity and specificity.
Insomnia has been investigated and diagnosed according to an instrument validated in a wide Italian population [29] . For the screening of SDB, we used the Berlin questionnaire which showed a sensitivity of 86% and a specificity of 77% in a western population [30] . A condition of clinically probable SDB was diagnosed in persons having a positive history of usual snoring or sleep apneas, who met the criteria for high risk of sleep apnea according to the Berlin questionnaire [30] . In brief, the questionnaire addresses the presence and frequency of snoring behavior, daytime sleepiness or fatigue and history of obesity and/or hypertension. Patients with persistent and frequent symptoms in two of these three domains were considered at high risk for SDB.
The presence of RLS was initially investigated with a simple question: 'In the evening, sitting or lying in bed, have you ever had a tidy sensation of urgency to move your legs to have relief and does this uncomfortable situation cause difficulties in starting or maintaining sleep?' In patients answering positively to this question, a clinically definite RLS (CD-RLS) was diagnosed in patients responding positively to four questions representing the criteria for the clinical diagnosis of RLS according to the International RLS Study Group [31, 32] .
At the time the study was carried out there were no available validated instruments or consensus on the criteria for the clinical diagnosis of RBD in cognitively impaired persons. In our study, a clinically probable RBD was diagnosed in patients presenting during sleep, about 1 h after falling asleep, rude movements and/ or vocalizations as if they were enacting terrifying nightmares, sometimes provoking harm to self or to their bed partner: these episodes do not necessarily cause the complete awakening of the subject.
The validity of this approach in assessing the presence of RBD in an aging and dementia cohort has been recently evaluated in a formal study that has reported a sensitivity of 98% and a specificity of 74%, considering polysomnography as the gold standard [33] .
Since specific questionnaires to assess EDS have not been formally validated in persons with cognitive decline, EDS was diagnosed from a direct clinical observation of the patient and/or on the caregiver's information about naps during the day.
In patients with any of the above-described sleep disturbances, we investigated the sleep quality with the Pittsburgh Sleep Quality Index (PSQI). With this questionnaire a cut-off score of 5 has a sensitivity of 89.6% and a specificity of 86.5% in distinguishing good and poor sleepers in noncognitively impaired persons [34, 35] . PSQI has been widely used also in old and cognitively impaired persons even though it has not been formally validated in such populations.
Data Analysis
Comparisons of numerical continuous variables were carried out with the analysis of variance with Bonferroni adjustment for multiple comparisons. Each included patient was classified according to the presence of the different investigated sleep disorders. The frequency of these disorders was compared in the five different diagnostic categories. The strength of association between any sleep disorder and type of dementia was estimated as relative risk and calculated as odds ratios, considering as reference category patients with AD. Relative risk estimates were calculated with logistic regression analysis adjusting for age, sex, severity of cognitive, functional impairment and of depressive symptoms. Ninety-five percent confidence limits of odds ratios were calculated using the standard errors of the coefficients of the logistic regression.
Results
We enrolled 431 patients: 204 (47.3%) had AD, 138 (32.0%) MCI, 43 (10.0%) VaD, 25 (5.8%) and 21 (4.9%) had FTD or LBD/PDD, respectively. The sex ratio was about 1: 1 in MCI patients, but there were slightly more men in the FTD and LBD/PDD groups. Men prevailed on women in the group with VaD, whereas women were the large majority among AD patients. These differences in sex distribution among different diagnostic categories were all statistically significant. In particular, women were significantly more represented in AD with respect to all the other diagnostic categories.
Mean age was over 70 in all the groups with the youngest mean age (71 years) for FTD and the oldest for LBD/ PDD (78.8 years) patients ( fig. 1 ). Persons with MCI were significantly younger than those with AD: patients with FTD were significantly younger than patients with other types of dementia. Mean education varied from a minimum of 5.8 years of formal schooling in patients with VaD to a maximum of 8.2 years in patients with MCI and the difference between VaD and MCI was statistically significant (p = 0.021). In persons with dementia, the lowest mean scores at MMSE were for patients with LBD/PDD, the highest for FTD. Persons with MCI had a mean MMSE score over the normality cut-off value of 23, and the score was significantly higher than that of all the other diagnostic groups. Patients with FTD had MMSE scores significantly higher than those with AD (p ! 0.001) and LBD/PDD (p ! 0.001). Functional capacities measured with the PSMS were only slightly compromised in MCI patients and significantly less compromised than in patients with dementia. AD and FTD patients were significantly less functionally compromised than LBD/PDD patients (p = 0.047 and p ! 0.001, respectively). Depressive symptoms were less severe in MCI patients followed by AD, VaD, FTD and LBD/PDD patients, but the only significant difference was between MCI and LBD/PDD (p = 0.020). Although there were different scores at the PSQI according to the different diagnoses, these differences were nonstatistically significant. The most frequent sleep disorder was SDB which was present in almost 60% of the patients, followed by EDS (50.1%), insomnia (49.9%), RBD (22.6%) and RLS (6.1%) ( table 1 ). Men more frequently had SDB, RBD and EDS, whereas RLS was more frequent in women. No difference was observed in the percentage of men and women with or without insomnia. No difference in the mean age was observed between persons with and without sleep disorders with the only exception of persons with insomnia who were significantly older than those unaffected (77 8 6.9 vs. 74.8 8 10.6 years, p ! 0.05). No other significant difference was observed in the level of cognitive and functional impairment, or in the quality of sleep (PSQI).
The different sleep disturbances occurred almost always in association ( table 2 ): the two disturbances that were more frequently found isolated were insomnia and EDS, 10 and 8% of the cases, respectively. RLS was always associated to other disturbances and all the persons with this syndrome had also SDB. Although occurring with high frequency associated one to another, no evident specific pattern of association emerged.
Every type of sleep disorder was present in each type of dementia and in persons with MCI, with the exception of RLS that was not recognized in LBD/PDD patients ( fig. 3 ). Taking AD patients as the reference category ( ta- ble 3 ), and adjusting for gender, age, MMSE and BDI-II scores, the presence of at least one of any of the inve stigated disturbances was two times more common in patients with VaD or LBD/PDD, but this difference was nonstatistically significant. Patients with MCI had a frequency of sleep disturbances of any type equal to that of patients with AD. Insomnia frequency was identical in AD and FTD patients but was about 2.5 and 1.5 times more frequent in VaD and LBD/PDD patients, respectively. SDB was about two times more frequent in patients with VaD than in those with AD. RBD was 2.6 times more frequent in LBD/PDD patients, whereas no difference of occurrence was observed for RLS among the different types of dementia. Excessive daytime sleepiness was more frequent among VaD and LBD/PDD patients than among AD patients, but these differences were only of borderline statistical significance. N umbers in parentheses are row percentages. SDB = Sleep-disordered breathing; RBD = REM behavior disorder; RLS = restless legs syndrome; EDS = excessive daytime sleepiness. 
Discussion
In this study, we investigated the occurrence of different sleep disorders in a consecutive series of patients with neurodegenerative dementias, vascular dementia or MCI. All the included patients were investigated with the same standardized instruments and procedures thus allowing a direct comparison of the frequency of occurrence of sleep disorders in the different types of cognitive impairments. We evaluated five sleep disturbances: insomnia, RBD, SDB, RLS and EDS plus global sleep quality by PSQI. In this population, almost 60% had symptoms clinically compatible with SDB and more than 50% had EDS and insomnia. The frequency of sleep disturbances found in this study is higher than that previously reported in AD. However, direct comparison among different studies is not possible due to the different sleep disturbances investigated and to the different modalities of investigation. In any case, to our knowledge, this is the only study that investigated a wide group of patients in a systematic way with several standardized questions and questionnaires, so a higher diagnostic sensitivity than in previous studies was expected.
RBD was particularly frequent and diagnosed in about 25% of the patients, whereas RLS, which was the less frequent disorder, had a prevalence of about 6% not dissimilar from that found in normal elderly people [32] .
The score of depressive symptoms was more severe in persons presenting any of the investigated sleep disorders. Depressive symptoms are common in older adults, especially among persons who are cognitively impaired, and insomnia is 2.5 times more frequent in older adults with depressed mood [36] . Our results confirm the association between depression, depressive symptoms and sleep disorders also in persons with dementia. The high frequency of sleep disorders reported in patients with dementia could be attributable to the neuropathological mechanisms of dementia or to the co-occurrence of depression, which is the most common neuropsychiatric disorder observed in dementias [37, 38] . However, this relationship might be bidirectional because there is also evidence that sleep disturbances can be a risk factor for depression and/or depressive symptoms [39] . No difference in the severity of cognitive impairment was observed in persons with or without any of the considered sleep disorders. This represents a controversial issue since an increase in the frequency of sleep disturbance in more severely compromised patients has been variably reported in previous studies [40] [41] [42] [43] . Otherwise, another study which used only PSQI in a cohort of patients with complaints of cognitive decline, showed that poor sleep quality was more common in nondemented versus demented patients [44] .
In this study, we have included community-dwelling patients with a CDR of three or lower and consequently patients with severe diseases were not represented. For this reason, an increase in frequency of sleep disorders cannot be excluded in patients with more severe symptoms than those we have studied.
SDB, RBD and EDS were more frequent in men than in women, whereas RLS was prevalent among women and insomnia was equally distributed in the two genders. A higher prevalence in men than in women of SDB and RBD is an established knowledge about these disorders and the higher prevalence of RLS in women is in agreement with a previous study on the elderly [32] .
With the exception of patients with insomnia who were significantly older, the mean ages of patients with or without any of the investigated sleep disorders were not different.
In our group of persons with cognitive impairment or dementia, 297 had one or more sleep disturbance and only 44 (14.8%) of them had an isolated disturbance, showing that sleep disturbances occur almost always in association whilst a nonspecific pattern of association was found. The tendency of disorders to occur in association suggests that the neurodegenerative or vascular damage causing dementia or cognitive impairment is so diffuse in these patients that many sleep control neural circuits are affected, causing multiple different sleep disorders in the same patient.
We found that patients with AD and MCI had almost the same frequency of any sleep disturbance not allowing us to give them a predicting value concerning the conversion from MCI to AD. Moreover, this result was unexpected since not all the MCI patients have an incipient AD and almost one third are expected to return to normal after 1 or 2 years. Vascular dementia patients had a frequency of any sleep disturbance that was two times higher than that observed in AD patients. The highest risk increase with respect to AD was for SBD and this result is in agreement with the high frequency of obstructive sleep apneas reported in patients with stroke [15] . One likely reason for the association between vascular damage and SDB might be that the two conditions have some common risk factors such as excessive body mass index and hypertension.
Patents with FTD were two times more frequently affected than patients with AD, although this increase was nonstatistically significant. A disruption of sleep/wake rhythms associated with increased nocturnal activity and decreased morning activity has already been reported in these patients [45] .
LBD and PDD had the highest frequency of occurrence of any sleep disturbances that were present in 90% of the patients. In LBD and PDD patients, insomnia and clinically probable RBD were significantly more frequent than in AD patients. The association of REM sleep disorders and LBD has already been detected in case reports [46] , and some studies have reported that RBD can precede for many years the onset of PDD and LBD [14, 47] . Our study confirms that symptoms characteristic of RBD are more frequent in LBD and PDD supporting the evidence that RBD is specifically linked to synucleinopathies [8] .
In patients with LBD or PDD we did not find any subject with RLS: this is an interesting result since contradictory evidence exists about the association of Parkinson's disease and RLS [48, 49] and no data have been published on RLS and LBD-PDD. Our results are evidence of the absence of any clear association between RLS and these diseases characterized by movement disorders and cognitive impairment.
Some limitations of the study should be noted: we studied a community-dwelling population, spontaneously presenting to neurological centers that might be selected for specific characteristics and even for the presence and type of sleep disorders. However, the general clinical and demographic characteristics of the studied population are very similar to those of any previously reported clinical convenience sample of patients firstly diagnosed with dementia. For this reason, we believe that our findings might be extended to all the patients seen by neurologists during clinical practice. Another limit could be related to the fact that we have studied our patients only on a clinical ground not using instrumental supports. Sleep disturbances are fully investigated and diagnosed with polysomnography and/or video-polysomnography, but these techniques are complex, expensive not always well tolerated by patients and consequently difficult to obtain in a wide number of subjects. Actigraphy is also difficult to be used extensively, so instrumental supports cannot be used as a screening to detect sleep disorders.
In conclusion, our results support previous evidence that sleep disturbances are particularly frequent in persons with dementia or cognitive impairment. In cognitively impaired populations, sleep disturbances tend to occur almost invariably in association. On clinical grounds, we have been able to appreciate a higher frequency of SDB in vascular dementia and of RBD in LBD/ PDD patients. The need for accurate diagnostic criteria for defining sleep-wake disturbances in AD and dementias is widely emphasized [50] : an accurate clinical investigation on the presence and type of sleep disorders is relevant for a better diagnostic characterization of patients and to optimize treatments. Instrumental supports should be considered in patients with specific symptoms and signs of sleep disorders as previously detected by a careful clinical investigation.
